COGNITIVE IMPAIRMENT AND DEMENTIA IN PARKINSON'S DISEASE

Actual Problems of Theoretical and Clinical Medicine, 2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.64854/2790-1289-2025-49-3-01
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Cognitive impairment is one of the most frequent and disabling non-motor manifestations of Parkinson's disease. It significantly reduces patients' quality of life, increases caregiver burden, and contributes to loss of independence. Early identification of cognitive decline is crucial for timely intervention and prevention of dementia progression. The purpose of the study. To determine the prevalence of cognitive impairment and identify predictors of progression to dementia among patients with Parkinson's disease. Material and Methods. A total of 106 patients with PD were examined and followed in outpatient clinics in Almaty. The diagnosis of Parkinson's disease was confirmed according to international criteria. Cognitive status was assessed using the Mini-Mental State Examination and Montreal Cognitive Assessment. Disease severity was evaluated using the Hoehn and Yahr scale and the Schwab and England Activities of Daily Living Scale. Demographic and clinical parameters, including age, education level, disease duration, and motor subtype, were analyzed. Results. Mild cognitive impairment was identified in 26.4% of patients, dementia in 34.9%, and no cognitive impairment in 38.7%. More pronounced cognitive decline was more common among older patients, those with lower educational attainment, disease duration over 10 years, and the akinetic-rigid subtype of Parkinson's disease. Regression analysis revealed the key predictors of dementia: disease onset after age 60, duration exceeding 19 years, low education level, and severe motor deficit. Conclusion. Cognitive impairment is common among Parkinson's disease patients and tends to progress with disease duration and severity. Early detection and systematic monitoring of cognitive functions are essential for implementing preventive measures, slowing dementia progression, and improving the quality of life of individuals with Parkinson's disease.